Loss of β-cell mass is posited to occur gradually over a long period of time in preclinical type 1 diabetes mellitus, as the first signs of β-cell autoimmunity generally emerge several years before clinical presentation. This concept has recently been challenged by observations of acute loss of β-cell mass in late-phase preclinical disease.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Knip, M. & Simell, O. Environmental triggers of type 1 diabetes. Cold Spring Harb. Perspect. Med. 2, a007690 (2012).
Eisenbarth, G. S. Type I diabetes mellitus. A chronic autoimmune disease. N. Engl. J. Med. 314, 1360–1368 (1986).
Campbell-Thompson, M. et al. Insulitis and ß-cell mass in the natural history of type 1 diabetes. Diabetes 65, 719–731 (2016).
Krogvold, L. et al. Function of isolated pancreatic islets from patients at onset of type 1 diabetes: insulin secretion can be restored after some days in a nondiabetogenic environment in vitro: results from the DiViD study. Diabetes 64, 2506–2512 (2015).
Rodriguez-Calvo, T. et al. Increase in pancreatic proinsulin and preservation of beta cell mass in autoantibody positive donors prior to type 1 diabetes onset. Diabetes https://doi.org/10.2337/db16-1343 (2017).
Ziegler, A. G. et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 309, 2473–2479 (2013).
Salonen, K. et al. Autoantibodies against zinc transporter 8 correlate with age, metabolic state and HLA-DR genotype in children with newly diagnosed type 1 diabetes. Diabetes Metab. Res. Rev. 29, 646–654 (2013).
Zimmet, P. Z. et al. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet. Med. 11, 299–303 (1994).
Herold, K. et al. β cell death and dysfunction during type 1 diabetes development in at-risk individuals. J. Clin. Invest. 125, 1163–1174 (2015).
Koskinen, M. et al. Reduced ß-cell function already in early preclinical type 1 diabetes. Eur. J. Endocrinol. 174, 251–259 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
M.K. declares that he has received a lecture fee from Merck Sharpe & Dohme (MSD), and that he is a board member and minor share holder (<5%) of Vactech Oy.
Rights and permissions
About this article
Cite this article
Knip, M. Loss of β-cell mass — an acute event before T1DM presentation?. Nat Rev Endocrinol 13, 253–254 (2017). https://doi.org/10.1038/nrendo.2017.33
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2017.33
This article is cited by
-
β-Cell mass versus function in type 1 diabetes mellitus: truth or dare?
Nature Reviews Endocrinology (2017)
-
Type 1 diabetes mellitus is a heterogeneous disease
Nature Reviews Endocrinology (2017)